Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $790000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 9.09% to $790000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, down 3.27% year-over-year, with the annual reading at $3.3 million for FY2025, 3.27% down from the prior year.
  • Depreciation & Amortization (CF) hit $790000.0 in Q4 2025 for Rapid Micro Biosystems, down from $804000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $869000.0 in Q4 2024 to a low of $300000.0 in Q2 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $702500.0 across 5 years, with a median of $785500.0 in 2023.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 25.0% in 2021 and later surged 127.67% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $450000.0 in 2021, then surged by 91.11% to $860000.0 in 2022, then dropped by 7.67% to $794000.0 in 2023, then increased by 9.45% to $869000.0 in 2024, then dropped by 9.09% to $790000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for RPID at $790000.0 in Q4 2025, $804000.0 in Q3 2025, and $811000.0 in Q2 2025.